Taiwan, Phoenix ink MOU on expanding semiconductor, AI cooperation
Exhibitor: JELLOX BIOTECH INC.
Date: 2026-05-14
Booth No.: M426

Taipei, Jan. 15 (CNA) Taiwan and the U.S. city of Phoenix on Thursday signed a memorandum of understanding (MOU) aimed at expanding cooperation on startup-driven innovation in semiconductors and AI-powered applications.
Speaking at the signing ceremony in Taipei, Phoenix Mayor Kate Gallego highlighted her background in business administration, saying it ensures she is able to support the growth of Taiwanese startups in her city.
"We'll help you grow your business," she said.
"You'll also, thanks to Taiwan Semiconductor Manufacturing Co. (TSMC) Arizona, have access to great Taiwanese food, Taiwanese banks, doctors who speak Mandarin," she said. "It can be all the comforts of home but access to the markets of the United States."
Gallego cited JelloX Biotech Inc., a Taiwanese startup specializing in 3D digital pathology imaging and AI analysis platforms, as an example of successful operations in Phoenix.
Its technologies can be applied in a range of settings, including improving the efficiency of colon cancer detection, she said.

According to Gallego, JelloX has begun operations at the Mayo Clinic Hospital in Phoenix, which offers a well-developed accelerator program.
The agreement, titled the Taiwan-Phoenix Strategic Technology Partnership, was signed by Startup Island Taiwan (SIT), the Industrial Technology Research Institute (ITRI), the city of Phoenix, the Greater Phoenix Economic Council (GPEC), and Tesoro VC.
According to SIT, the MOU aims to help U.S. startups connect with Taiwan's semiconductor research and development and manufacturing ecosystem, while supporting Taiwanese startups in using Phoenix as a foothold and launchpad to enter the U.S. market.
It also seeks to encourage startups from both sides to participate in accelerators, incubators and soft-landing programs. SIT is a public-private partnership between the Taiwanese government and a group of startups aimed at helping Taiwanese startups boost their international presence.
The initiative will focus on AI, semiconductors and advanced packaging, physical AI intelligent systems, advanced manufacturing, photonics, dual-use technologies, and AI-enabled healthcare applications, SIT said.
The new MOU builds on an earlier agreement signed in 2023 between SIT and GPEC, which focused on facilitating information exchanges on industry and investment projects, organizing joint business missions, promoting soft-landing opportunities for Taiwanese startups, and advancing joint initiatives.
Targeted fields under that agreement included cybersecurity, green energy technology, 5G, information and communications technology (ICT), and semiconductors.
National Development Council Deputy Minister Jan Fang-guan (詹方冠) said the successful expansion of several Taiwanese startups in Phoenix since 2024 demonstrates that "combining Taiwan's R&D power with Phoenix's market and clinical environment is a win-win strategy."
Phoenix is home to two TSMC wafer fabrication plants, with four more planned under a US$165 billion investment package -- the largest single foreign direct investment in U.S. history.
More Exhibitor's Press Release
- 20 Years of MDG: From CRO to CIO MEDGAEA LIFE SCIENCES LTD. / 2026-07-07
- Accelerating Cell, Gene and Regenerative Medicine Development with an Integrated Platform MEDGAEA LIFE SCIENCES LTD. / 2026-07-07
- MDG Connects Japan's Leading Nonclinical Research Resources to Accelerate Advanced Therapies MEDGAEA LIFE SCIENCES LTD. / 2026-07-07
- NYCU Pavilion at BIO Asia–Taiwan 2026 NATIONAL YANG MING CHIAO TUNG UNIVERSITY / 2026-07-07
- US-Based, Globally Connected: Building a Global Platform for Precision Cancer Testing EG BIOMED US INC. / 2026-07-07
- Advancing First Line Therapy for Metastatic Pancreatic Cancer: Global Phase 3 Study of Antroquinonol GOLDEN BIOTECHNOLOGY CORP. / 2026-07-06
- How to Run Clinical Trials Efficiently EFFICIENT PHARMA MANAGEMENT CORP. / 2026-07-03
- Noah AI Announces AI Analyst — Designed for Biopharma Investment and Business Decision-Making SHANGHAI NOAH AI TECHNOLOGY CO., LTD. / 2026-07-01
- EG Officially Launches Nationwide Telehealth Platform, Delivering an End-to-End Cancer Testing EG BIOMED US INC. / 2026-07-01
- Comprehensive GMP-Grade Exosome Purification and Quality Control Solutions COLD SPRING BIOTECH CORP. / 2026-07-01
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-01
- BrainChild XH13 Cloud Logger Delivers Environmental Visibility for Labs and Storage BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-01
- Model-informed CMC Development of Amorphous solid dispersions using continuous melt extrusion GETINGE GROUP TAIWAN CO., LTD. / 2026-07-01
- EffPha – 以專家為核心的臨床試驗受託機構(CRO),協助您的藥物研發 EFFICIENT PHARMA MANAGEMENT CORP. / 2026-06-30
- EffPha Meets You at BIO Asia-Taiwan Exhibition 2026 EFFICIENT PHARMA MANAGEMENT CORP. / 2026-06-30
- LabWare European and North American Customer Education Conferences Conclude LABWARE TAIWAN CO., LTD. / 2026-06-29
- Integrated Bio × Lingan Water-Free Cell Thawing Solution INTEGRATED BIO LTD. / 2026-06-29
- LabWare Named Best IT Solution at the Labmate Awards for Excellence 2025 LABWARE TAIWAN CO., LTD. / 2026-06-22
- Next Generations Therapy Manufacturing LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- The Fastest and Safest Depth Filtration LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17